PFIZER INC Dividends Payable, Current
PFIZER INC (PFE) had Dividends Payable, Current of $2.45 billion as of 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:DividendsPayableCurrent · last filed 2026-08-04
- 2026-06-28: Dividends Payable, Current $2.45B.
- 2026-03-29: Dividends Payable, Current $0.00.
- 2025-12-31: Dividends Payable, Current $2.44B.
- 2025-09-28: Dividends Payable, Current $0.00.
| Period end | Dividends Payable, Current | Dividends Payable, Current as first filed |
|---|---|---|
| 2026-06-28 | $2.45B 10-Q · filed 2026-08-04 | |
| 2026-03-29 | $0.00 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $2.44B 10-Q · filed 2026-08-04 | |
| 2025-09-28 | $0.00 10-Q · filed 2025-11-04 | |
| 2025-06-29 | $2.44B 10-Q · filed 2025-08-05 | |
| 2025-03-30 | $0.00 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $2.44B 10-K · filed 2026-02-26 | |
| 2024-09-29 | $0.00 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $2.38B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $2.37B 10-K · filed 2025-02-27 | |
| 2023-10-01 | $0.00 10-Q · filed 2023-11-08 | |
| 2023-07-02 | $2.31B 10-Q · filed 2023-08-09 | |
| 2023-04-02 | $0.00 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.30B 10-K · filed 2024-02-22 | |
| 2022-10-02 | $2.25B 10-Q · filed 2022-11-09 | |
| 2022-07-03 | $2.25B 10-Q · filed 2022-08-10 | |
| 2022-04-03 | $0.00 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $2.25B 10-K · filed 2023-02-23 | |
| 2021-10-03 | $2.19B 10-Q · filed 2021-11-12 | |
| 2021-07-04 | $2.18B 10-Q · filed 2021-08-12 | |
| 2021-04-04 | $0.00 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $2.16B 10-K · filed 2022-02-24 | |
| 2020-09-27 | $2.11B 10-Q · filed 2020-11-05 | |
| 2020-06-28 | $2.11B 10-Q · filed 2020-08-06 | |
| 2020-03-29 | $0.00 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.10B 10-K · filed 2021-02-25 | |
| 2019-09-29 | $1.99B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.99B 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.05B 10-K · filed 2020-02-27 | |
| 2018-09-30 | $1.96B 10-Q · filed 2018-11-08 | |
| 2018-07-01 | $1.98B 10-Q · filed 2018-08-09 | |
| 2018-04-01 | $0.00 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.03B 10-K · filed 2019-02-28 | |
| 2017-10-01 | $1.91B 10-Q · filed 2017-11-09 | |
| 2017-07-02 | $1.90B 10-Q · filed 2017-08-10 | |
| 2017-04-02 | $0.00 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $1.94B 10-K · filed 2018-02-22 | |
| 2016-10-02 | $1.82B 10-Q · filed 2016-11-10 | |
| 2016-07-03 | $1.82B 10-Q · filed 2016-08-11 | |
| 2016-04-03 | $0.00 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $1.85B 10-K · filed 2017-02-23 | |
| 2015-09-27 | $1.73B 10-Q · filed 2015-11-05 | |
| 2015-06-28 | $1.73B 10-Q · filed 2015-08-06 | |
| 2015-03-29 | $0.00 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.71B 10-K · filed 2016-02-29 | |
| 2014-09-28 | $0.00 10-Q · filed 2014-11-06 | |
| 2014-06-29 | $1.65B 10-Q · filed 2014-08-07 | |
| 2014-03-30 | $1.00M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $1.66B 10-K · filed 2015-02-27 | |
| 2013-09-29 | $1.00M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $1.69B 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $5.00M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $1.73B 10-K · filed 2014-02-28 | $1.73B 10-K · filed 2013-02-28 |
| 2012-09-30 | $1.00M 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $1.83B 10-Q · filed 2012-08-09 | |
| 2012-04-01 | $1.00M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $1.80B 10-K · filed 2013-02-28 | |
| 2010-12-31 | $1.60B 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |